Contract # SPM2D013D0005
    PSC 6505 Drugs And Biologicals
    Set-Aside None
    Status Past Ordering Date
    POP 5/22/13 - 5/21/14 (11 months)
  • Aggregate Dollars Obligated

    $1.5m

  • Aggregate Base & Exercised Options Value

    $1.5m

  • Aggregate Ceiling

    $1.5m

  • Pricing Type

    Firm Fixed Price

  • Single or Multiple Award

    Single Award

  • Extent Competed

    Full and Open Competition, 1 offer(s)

Agency Contract # Vendor NAICS PSC Set-Aside Last Active Kickoff Completion Ceiling % Ob.
DLA SPM2D013D0005-SPE2D318F5174 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 Not Reported 3/13/18 3/13/18 3/21/18
  • 4541235807!CLONAZEPAM TABLETS, USP., 1.0 MG, 100 TA
DLA SPM2D013D0005-SPE2D318F4276 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 Not Reported 2/21/18 2/21/18 2/22/18
  • 4540967722!CLONAZEPAM TABLETS USP 0.5 MG 100S BT
DLA SPM2D013D0005-SPE2D318F3487 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 Not Reported 2/15/18 2/15/18 2/15/18
  • 4540915412!DIAZEPAM TABLETS USP, 5 MG, 100 TABLETS
DLA SPM2D013D0005-SPE2D318F3689 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 Not Reported 2/8/18 2/8/18 2/9/18
  • 4540832622!TENECTEPLASE INTRAVENOUS KIT 50MG
DLA SPM2D013D0005-SPE2D318F3642 Delivery Order Genentech Usa, Inc. South San Franc... 325411 6505 Not Reported 2/5/18 2/5/18 2/8/18
  • 4540788136!CLONAZEPAM TABLETS USP 0.5 MG 100S BT